Connect With Us
Subscribe Now
Log In
Home
News
Education
Health
Tech
STEM
Advanced Manufacturing & Logistics
Life Sciences
Ag INnovation
INPower
Videos
Big Wigs
Submit Big Wigs
Events
Innovate Southwest Indiana â Evansville
Innovate West Central Indiana – Terre Haute
Innovate East Central – Muncie
Innovate Northeast Indiana – Fort Wayne
Newsletters
Podcasts
On-Air
TV & Radio Listings
Content Studio
Sponsored Content
Contact
About IIB
Meet the Team
Contact Us
Advertise
Gift Cards
Flagship Stations
Gerry’s Message
Speaking Engagement Request
Search
GO
Connect With Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Articles published by InflaRx N.V.
InflaRx to Present Late-Breaking Pre-clinical Data on Izicopan at Kidney Week 2026
October 02, 2026
From
InflaRx N.V.
Via
GlobeNewswire
Tickers
IFRX
InflaRx Appoints Gabriela Alperovich, MD, PhD, as Senior Vice President & Global Head of Clinical Development
October 01, 2026
From
InflaRx N.V.
Via
GlobeNewswire
Tickers
IFRX
InflaRx to Host Virtual Capital Markets Day
September 21, 2026
From
InflaRx N.V.
Via
GlobeNewswire
Tickers
IFRX
InflaRx Announces Participation in September Investor Conferences
August 20, 2026
From
InflaRx N.V.
Via
GlobeNewswire
Tickers
IFRX
InflaRx Reports Second Quarter 2026 Results and Highlights Key Achievements and Expected Milestones
August 06, 2026
From
InflaRx N.V.
Via
GlobeNewswire
Tickers
IFRX
InflaRx to Report Second Quarter 2026 Results on August 6, 2026
July 30, 2026
From
InflaRx N.V.
Via
GlobeNewswire
Tickers
IFRX
InflaRx Assessing Feasibility of Broadened Strategy for ANCA‑Associated Vasculitis in Europe Following EMA Recommendation on Tavneos
June 30, 2026
From
InflaRx N.V.
Via
GlobeNewswire
Tickers
IFRX
InflaRx Announces Closing of $150 Million Underwritten Offering of Ordinary Shares
May 08, 2026
From
InflaRx N.V.
Via
GlobeNewswire
Tickers
IFRX
InflaRx Announces Pricing of $150 Million Underwritten Offering of Ordinary Shares
May 06, 2026
From
InflaRx N.V.
Via
GlobeNewswire
Tickers
IFRX
InflaRx Announces Advancement of Izicopan in ANCA-Associated Vasculitis and Select Renal Diseases
May 06, 2026
From
InflaRx N.V.
Via
GlobeNewswire
Tickers
IFRX
InflaRx Announces Initiation of its Commitment Program for GOHIBIC®(vilobelimab) to Help Broaden Access for Eligible Patients
January 25, 2024
From
InflaRx N.V.
Via
GlobeNewswire
Tickers
IFRX
InflaRx Receives FDA Emergency Use Authorization for Gohibic (vilobelimab) for Treatment of Critically Ill COVID-19 Patients
April 04, 2023
From
InflaRx N.V.
Via
GlobeNewswire
Tickers
IFRX
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.